Visual outcome 6, 12, 18, and 24 months after radiotherapy
| At 6 months No of eyes (%) | At 12 months No of eyes (%) | At 18 months No of eyes (%) | At 24 months No of eyes (%) | |
|---|---|---|---|---|
| Classic CNV group: | ||||
| Improved | 3/6 (50) | 3/5 (60) | 1/2 (50) | 1/2 (50) |
| Stable | 2/6 (33.3) | 0 | 0 | 0 |
| Decreased | 1/6 (16.7) | 2/5 (40) | 1/2 (50) | 1/2 (50) |
| Occult CNV group: | ||||
| Improved | 66/165 (40) | 34/106 (32.1) | 17/66 (25.7) | 11/40 (27.5) |
| Stable | 57/165 (34.5) | 49/106 (46.2) | 26/66 (39.4) | 14/40 (35) |
| Decreased | 42/165 (25.5) | 23/106 (21.7) | 23/66 (34.9) | 15/40 (37.5) |
| Mixed CNV group: | ||||
| Improved | 14/60 (23.3) | 16/43 (37.2) | 10/24 (41.7) | 6/13 (46.1) |
| Stable | 30/60 (50) | 15/43 (34.9) | 5/24 (20.8) | 1/13 (7.8) |
| Decreased | 16/60 (26.7) | 12/43 (27.9) | 9/24 (37.5) | 6/13 (46.1) |
| Global results: | ||||
| Improved | 83/231 (36) | 53/154 (34.4) | 29/94 (30.9) | 18/55 (32.7) |
| Stable | 89/231 (38.5) | 64/154 (41.6) | 31/94 (33) | 15/55 (27.3) |
| Decreased | 59/231 (25.5) | 37/154 (24) | 34/94 (36.2) | 22/55 (40) |